Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096027 · ClinicalTrials.gov registry record · Phase 4
Cabergoline Before or After Oocyte Collection for Follicular Resolution
A Phase 4 study of Infertility, Female, sponsored by Fertility Center of Las Vegas.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04096027: Completed Phase 4 study of Infertility, Female, sponsored by Fertility Center of Las Vegas.
NCT04096027 is a Phase 4 study of Infertility, Female that has completed, run by Fertility Center of Las Vegas. The registered enrollment target is 70 participants, below the 379-participant average among 18 other Infertility, Female trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04096027, a Phase 4 study of Infertility, Female, has completed, sponsored by Fertility Center of Las Vegas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized trial comparing the efficacy of two different times of administration of cabergoline in patients undergoing controlled ovarian stimulation and oocyte collection.
Primary Outcome
Self-assessed discomfort level
Conditions Studied
Interventions
- DRUG Cabergoline Pill
Study Locations (1)
Nevada
- Fertility Center of Las vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2021-06-10 |
| Phase | Phase 4 |
What the finished NCT04096027 record still lists
NCT04096027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 379-participant average among 18 other Infertility, Female trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Cabergoline Pill is the first listed.
NCT04096027 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT04096027 about?
NCT04096027 is a clinical study titled "Cabergoline Before or After Oocyte Collection for Follicular Resolution". Randomized trial comparing the efficacy of two different times of administration of cabergoline in patients undergoing controlled ovarian stimulation and oocyte collection.
What is the current status of trial NCT04096027?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2019-09-23. Estimated completion is 2021-06-10.
What conditions does trial NCT04096027 study?
This clinical trial studies the following conditions: Infertility, Female.
What interventions are being tested in trial NCT04096027?
The interventions under investigation include: Cabergoline Pill (DRUG).
Who is sponsoring clinical trial NCT04096027?
This trial is sponsored by Fertility Center of Las Vegas, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04096027 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility, Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04096027's enrollment target sits among peer trials
70 11th of 18 higher than 8 of 18 other Infertility, Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility, Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
RECRUITING · Phase 4
-
Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval
COMPLETED · Phase 4
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
RECRUITING · NA
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI